MOUSE GENE MANIPULATION CORE (CORE E) ABSTRACT The primary objective of the Mouse Gene Manipulation Core is to provide all our IDDRC investigators with a centralized, affordable and quality-controlled service, using state-of-the art genome editing technology, for the rapid and efficient generation of genetically altered mouse lines. Our goal is aid our PIs in their work on identifying the role of particular genes in the development of the nervous system and in modelling intellectual disability and neurodevelopmental disorders, with a view in particular of identifying preclinically, novel biomarkers of these disorders and for evaluating the efficacy of new therapeutic approaches. Although manipulation of the mouse genome has been well established for several decades using homologous combination in embryonic stem cells for gene targeting and random insertion of DNA in zygotes for making transgenic mice, and this Core has very effectively used these approaches to generate many mouse models of neurodevelopmental disorders, during the course of the present grant cycle transformative advances have been made in our capacity for genome editing. This core has enthusiastically embraced and mastered the new CRISPR/Cas9 technology for disrupting gene expression by base insertion/deletion (INDELS), and using homology directed repair (HDR) for introducing mutations, inserting reporters, Cre or Flp drivers and indeed making many kinds of changes to the genome ? in a manner that is both efficient and fast. We will continue to offer our standard technology since there are users and uses that favor this but anticipate that CRISPR/Cas9 and its evolution will largely take over. The technology has caused immense excitement in the IDDRC community and the demand for our services are set to increase substantially, so that the IDDRC can provide parallel preclinical and clinical phenotyping and efficacy studies. To aid in the uptake of genome editing the core will offer consultation services on the best approach for PIs to use for particular projects, advice on selection of guide RNAs, genotyping and colony management, as well as a new cryopreservation service. Collectively the new services will offer the IDDRC mouse models faster and cheaper with the capacity to preserve these for alter use or sharing.

Agency
National Institute of Health (NIH)
Institute
Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)
Type
Specialized Center--Cooperative Agreements (U54)
Project #
5U54HD090255-05
Application #
10003045
Study Section
Special Emphasis Panel (ZHD1)
Project Start
Project End
Budget Start
2020-06-01
Budget End
2021-05-31
Support Year
5
Fiscal Year
2020
Total Cost
Indirect Cost
Name
Boston Children's Hospital
Department
Type
DUNS #
076593722
City
Boston
State
MA
Country
United States
Zip Code
02115
Nowak-Sliwinska, Patrycja; Alitalo, Kari; Allen, Elizabeth et al. (2018) Consensus guidelines for the use and interpretation of angiogenesis assays. Angiogenesis 21:425-532
Di Gioia, Silvio Alessandro; Shaaban, Sherin; Tüysüz, Beyhan et al. (2018) Recessive MYF5 Mutations Cause External Ophthalmoplegia, Rib, and Vertebral Anomalies. Am J Hum Genet 103:115-124
Shaaban, Sherin; MacKinnon, Sarah; Andrews, Caroline et al. (2018) Genome-Wide Association Study Identifies a Susceptibility Locus for Comitant Esotropia and Suggests a Parent-of-Origin Effect. Invest Ophthalmol Vis Sci 59:4054-4064
Tyssowski, Kelsey M; DeStefino, Nicholas R; Cho, Jin-Hyung et al. (2018) Different Neuronal Activity Patterns Induce Different Gene Expression Programs. Neuron 98:530-546.e11
Bardai, Farah H; Wang, Liqun; Mutreja, Yamini et al. (2018) A Conserved Cytoskeletal Signaling Cascade Mediates Neurotoxicity of FTDP-17 Tau Mutations In Vivo. J Neurosci 38:108-119
Modi, Meera E; Sahin, Mustafa (2018) The Way Forward for Mechanism-Based Therapeutics in Genetically Defined Neurodevelopmental Disorders. Clin Pharmacol Ther 104:603-606
Wong, Man Yan; Liu, Changliang; Wang, Shan Shan H et al. (2018) Liprin-?3 controls vesicle docking and exocytosis at the active zone of hippocampal synapses. Proc Natl Acad Sci U S A 115:2234-2239
Wojcik, Monica H; Wierenga, Klaas J; Rodan, Lance H et al. (2018) Beta-Ketothiolase Deficiency Presenting with Metabolic Stroke After a Normal Newborn Screen in Two Individuals. JIMD Rep 39:45-54
Hong, Y Kate; Burr, Eliza F; Sanes, Joshua R et al. (2018) Heterogeneity of retinogeniculate axon arbors. Eur J Neurosci :
Sundberg, Maria; Tochitsky, Ivan; Buchholz, David E et al. (2018) Purkinje cells derived from TSC patients display hypoexcitability and synaptic deficits associated with reduced FMRP levels and reversed by rapamycin. Mol Psychiatry 23:2167-2183

Showing the most recent 10 out of 498 publications